context stringlengths 21 33.9k | category stringclasses 2
values | entity stringlengths 1 12 | entity_type stringclasses 5
values | query stringlengths 97 3.31k | answer stringlengths 12 169 |
|---|---|---|---|---|---|
Our authorized share capital is 300,000,000 shares of common stock and 100,000,000 shares of preferred stock, of which 25,000,000 is designated Series A, 25,000,000 is designated as Series A-1 and 50,000,000 is undesignated. As of December 31, 2024 | text | 50000000 | sharesItemType | text: <entity> 50000000 </entity> <entity type> sharesItemType </entity type> <context> Our authorized share capital is 300,000,000 shares of common stock and 100,000,000 shares of preferred stock, of which 25,000,000 is designated Series A, 25,000,000 is designated as Series A-1 and 50,000,000 is undesignated. As of December 31, 2024 </context> | us-gaap:PreferredStockSharesAuthorized |
During the year ended December 31, 2024, we sold 569,382 shares on a spot basis under the 2022 ATM Program for approximately $ 467 million, net of commissions and other offering expenses, and we sold 755,298 shares on a spot basis under the 2024 ATM Program for approximately $ 697 million, net of commissions and other offering expenses. | text | 569382 | sharesItemType | text: <entity> 569382 </entity> <entity type> sharesItemType </entity type> <context> During the year ended December 31, 2024, we sold 569,382 shares on a spot basis under the 2022 ATM Program for approximately $ 467 million, net of commissions and other offering expenses, and we sold 755,298 shares on a spot basis under the 2024 ATM Program for approximately $ 697 million, net of commissions and other offering expenses. </context> | us-gaap:StockIssuedDuringPeriodSharesNewIssues |
During the year ended December 31, 2024, we sold 569,382 shares on a spot basis under the 2022 ATM Program for approximately $ 467 million, net of commissions and other offering expenses, and we sold 755,298 shares on a spot basis under the 2024 ATM Program for approximately $ 697 million, net of commissions and other offering expenses. | text | 467 | monetaryItemType | text: <entity> 467 </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2024, we sold 569,382 shares on a spot basis under the 2022 ATM Program for approximately $ 467 million, net of commissions and other offering expenses, and we sold 755,298 shares on a spot basis under the 2024 ATM Program for approximately $ 697 million, net of commissions and other offering expenses. </context> | us-gaap:SaleOfStockConsiderationReceivedOnTransaction |
During the year ended December 31, 2024, we sold 569,382 shares on a spot basis under the 2022 ATM Program for approximately $ 467 million, net of commissions and other offering expenses, and we sold 755,298 shares on a spot basis under the 2024 ATM Program for approximately $ 697 million, net of commissions and other offering expenses. | text | 755298 | sharesItemType | text: <entity> 755298 </entity> <entity type> sharesItemType </entity type> <context> During the year ended December 31, 2024, we sold 569,382 shares on a spot basis under the 2022 ATM Program for approximately $ 467 million, net of commissions and other offering expenses, and we sold 755,298 shares on a spot basis under the 2024 ATM Program for approximately $ 697 million, net of commissions and other offering expenses. </context> | us-gaap:StockIssuedDuringPeriodSharesNewIssues |
During the year ended December 31, 2024, we sold 569,382 shares on a spot basis under the 2022 ATM Program for approximately $ 467 million, net of commissions and other offering expenses, and we sold 755,298 shares on a spot basis under the 2024 ATM Program for approximately $ 697 million, net of commissions and other offering expenses. | text | 697 | monetaryItemType | text: <entity> 697 </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2024, we sold 569,382 shares on a spot basis under the 2022 ATM Program for approximately $ 467 million, net of commissions and other offering expenses, and we sold 755,298 shares on a spot basis under the 2024 ATM Program for approximately $ 697 million, net of commissions and other offering expenses. </context> | us-gaap:SaleOfStockConsiderationReceivedOnTransaction |
On April 3, 2023, we issued additional shares in our Indonesian operating entity to a third party investor for $ 25 million, which resulted in the third party investor owning a 25 % interest in the entity. | text | 25 | monetaryItemType | text: <entity> 25 </entity> <entity type> monetaryItemType </entity type> <context> On April 3, 2023, we issued additional shares in our Indonesian operating entity to a third party investor for $ 25 million, which resulted in the third party investor owning a 25 % interest in the entity. </context> | us-gaap:ProceedsFromMinorityShareholders |
Under the terms of the shareholders’ agreement, the investor may put its 25 % ownership stake in the entity to us for a maximum exercise price of $ 25 million, subject to certain contingent conditions. Accordingly, we present the investor’s contingently redeemable non-controlling interest ("NCI") outside of permanent equity at the higher of its maximum redemption amount of $ 25 million and its balance after attribution of gains and losses in the consolidated balance sheets. There were no changes in the carrying value of the redeemable NCI for the year ended December 31, 2024. | text | 25 | monetaryItemType | text: <entity> 25 </entity> <entity type> monetaryItemType </entity type> <context> Under the terms of the shareholders’ agreement, the investor may put its 25 % ownership stake in the entity to us for a maximum exercise price of $ 25 million, subject to certain contingent conditions. Accordingly, we present the investor’s contingently redeemable non-controlling interest ("NCI") outside of permanent equity at the higher of its maximum redemption amount of $ 25 million and its balance after attribution of gains and losses in the consolidated balance sheets. There were no changes in the carrying value of the redeemable NCI for the year ended December 31, 2024. </context> | us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance |
Under the terms of the shareholders’ agreement, the investor may put its 25 % ownership stake in the entity to us for a maximum exercise price of $ 25 million, subject to certain contingent conditions. Accordingly, we present the investor’s contingently redeemable non-controlling interest ("NCI") outside of permanent equity at the higher of its maximum redemption amount of $ 25 million and its balance after attribution of gains and losses in the consolidated balance sheets. There were no changes in the carrying value of the redeemable NCI for the year ended December 31, 2024. | text | 25 | monetaryItemType | text: <entity> 25 </entity> <entity type> monetaryItemType </entity type> <context> Under the terms of the shareholders’ agreement, the investor may put its 25 % ownership stake in the entity to us for a maximum exercise price of $ 25 million, subject to certain contingent conditions. Accordingly, we present the investor’s contingently redeemable non-controlling interest ("NCI") outside of permanent equity at the higher of its maximum redemption amount of $ 25 million and its balance after attribution of gains and losses in the consolidated balance sheets. There were no changes in the carrying value of the redeemable NCI for the year ended December 31, 2024. </context> | us-gaap:RedeemableNoncontrollingInterestEquityRedemptionValue |
In addition, as of December 31, 2024, we recorded a short-term dividend payable of $ 16 million and a long-term dividend payable of $ 13 million related to RSUs that have not yet vested. As of December 31, 2023, we recorded a short-term dividend payable of $ 14 million and a long-term dividend payable of $ 12 million related to RSUs that have not yet vested. | text | 16 | monetaryItemType | text: <entity> 16 </entity> <entity type> monetaryItemType </entity type> <context> In addition, as of December 31, 2024, we recorded a short-term dividend payable of $ 16 million and a long-term dividend payable of $ 13 million related to RSUs that have not yet vested. As of December 31, 2023, we recorded a short-term dividend payable of $ 14 million and a long-term dividend payable of $ 12 million related to RSUs that have not yet vested. </context> | us-gaap:DividendsPayableCurrent |
In addition, as of December 31, 2024, we recorded a short-term dividend payable of $ 16 million and a long-term dividend payable of $ 13 million related to RSUs that have not yet vested. As of December 31, 2023, we recorded a short-term dividend payable of $ 14 million and a long-term dividend payable of $ 12 million related to RSUs that have not yet vested. | text | 14 | monetaryItemType | text: <entity> 14 </entity> <entity type> monetaryItemType </entity type> <context> In addition, as of December 31, 2024, we recorded a short-term dividend payable of $ 16 million and a long-term dividend payable of $ 13 million related to RSUs that have not yet vested. As of December 31, 2023, we recorded a short-term dividend payable of $ 14 million and a long-term dividend payable of $ 12 million related to RSUs that have not yet vested. </context> | us-gaap:DividendsPayableCurrent |
The 2004 Purchase Plan permits eligible employees to purchase common stock on favorable terms via payroll deductions of up to 15 % of the employee's cash compensation, subject to certain share and statutory dollar limits. Two overlapping offering periods commence during each calendar year, on each of February 15 and August 15 or such other periods or dates as determined by the Talent, Culture and Compensation Committee of the Board of Directors (the "Compensation Committee") from time to time, and the offering periods last up to 24 months with a purchase date every 6 months. The price of each share purchased is 85 % of the lower of a) the fair value per share of common stock on the last trading day before the commencement of the applicable offering period or b) the fair value per share of common stock on the purchase date. | text | 15 | percentItemType | text: <entity> 15 </entity> <entity type> percentItemType </entity type> <context> The 2004 Purchase Plan permits eligible employees to purchase common stock on favorable terms via payroll deductions of up to 15 % of the employee's cash compensation, subject to certain share and statutory dollar limits. Two overlapping offering periods commence during each calendar year, on each of February 15 and August 15 or such other periods or dates as determined by the Talent, Culture and Compensation Committee of the Board of Directors (the "Compensation Committee") from time to time, and the offering periods last up to 24 months with a purchase date every 6 months. The price of each share purchased is 85 % of the lower of a) the fair value per share of common stock on the last trading day before the commencement of the applicable offering period or b) the fair value per share of common stock on the purchase date. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate |
The 2004 Purchase Plan permits eligible employees to purchase common stock on favorable terms via payroll deductions of up to 15 % of the employee's cash compensation, subject to certain share and statutory dollar limits. Two overlapping offering periods commence during each calendar year, on each of February 15 and August 15 or such other periods or dates as determined by the Talent, Culture and Compensation Committee of the Board of Directors (the "Compensation Committee") from time to time, and the offering periods last up to 24 months with a purchase date every 6 months. The price of each share purchased is 85 % of the lower of a) the fair value per share of common stock on the last trading day before the commencement of the applicable offering period or b) the fair value per share of common stock on the purchase date. | text | 85 | percentItemType | text: <entity> 85 </entity> <entity type> percentItemType </entity type> <context> The 2004 Purchase Plan permits eligible employees to purchase common stock on favorable terms via payroll deductions of up to 15 % of the employee's cash compensation, subject to certain share and statutory dollar limits. Two overlapping offering periods commence during each calendar year, on each of February 15 and August 15 or such other periods or dates as determined by the Talent, Culture and Compensation Committee of the Board of Directors (the "Compensation Committee") from time to time, and the offering periods last up to 24 months with a purchase date every 6 months. The price of each share purchased is 85 % of the lower of a) the fair value per share of common stock on the last trading day before the commencement of the applicable offering period or b) the fair value per share of common stock on the purchase date. </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent |
: In 2020, both our Board of Directors and our stockholders approved the 2020 Equity Plan, which provides for the grant of stock options, including incentive stock options and nonqualified stock options, stock appreciation rights, RSAs, RSUs, other stock-based incentive awards, dividend equivalents, and cash-based incentive awards. The 2020 Equity Plan's awards may be granted to employees, non-employee members of the Board and consultants. Equity awards granted under the 2020 Equity Incentive Plan generally vest over four years . The maximum numbers of shares of our common stock available for issuance under the 2020 Equity Plan is equal to the sum of 4 million shares and the shares transferred from the 2000 Equity Incentive Plan. | text | 4 | sharesItemType | text: <entity> 4 </entity> <entity type> sharesItemType </entity type> <context> : In 2020, both our Board of Directors and our stockholders approved the 2020 Equity Plan, which provides for the grant of stock options, including incentive stock options and nonqualified stock options, stock appreciation rights, RSAs, RSUs, other stock-based incentive awards, dividend equivalents, and cash-based incentive awards. The 2020 Equity Plan's awards may be granted to employees, non-employee members of the Board and consultants. Equity awards granted under the 2020 Equity Incentive Plan generally vest over four years . The maximum numbers of shares of our common stock available for issuance under the 2020 Equity Plan is equal to the sum of 4 million shares and the shares transferred from the 2000 Equity Incentive Plan. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant |
The total fair value of RSUs vested and released during the years ended December 31, 2024, 2023 and 2022 was $ 594 million, $ 498 million and $ 462 million, respectively. | text | 594 | monetaryItemType | text: <entity> 594 </entity> <entity type> monetaryItemType </entity type> <context> The total fair value of RSUs vested and released during the years ended December 31, 2024, 2023 and 2022 was $ 594 million, $ 498 million and $ 462 million, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue |
The total fair value of RSUs vested and released during the years ended December 31, 2024, 2023 and 2022 was $ 594 million, $ 498 million and $ 462 million, respectively. | text | 498 | monetaryItemType | text: <entity> 498 </entity> <entity type> monetaryItemType </entity type> <context> The total fair value of RSUs vested and released during the years ended December 31, 2024, 2023 and 2022 was $ 594 million, $ 498 million and $ 462 million, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue |
The total fair value of RSUs vested and released during the years ended December 31, 2024, 2023 and 2022 was $ 594 million, $ 498 million and $ 462 million, respectively. | text | 462 | monetaryItemType | text: <entity> 462 </entity> <entity type> monetaryItemType </entity type> <context> The total fair value of RSUs vested and released during the years ended December 31, 2024, 2023 and 2022 was $ 594 million, $ 498 million and $ 462 million, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue |
During the years ended December 31, 2024, 2023 and 2022, we capitalized $ 77 million, $ 60 million and $ 46 million, respectively, of stock-based compensation expense as construction in progress in property, plant and equipment. | text | 77 | monetaryItemType | text: <entity> 77 </entity> <entity type> monetaryItemType </entity type> <context> During the years ended December 31, 2024, 2023 and 2022, we capitalized $ 77 million, $ 60 million and $ 46 million, respectively, of stock-based compensation expense as construction in progress in property, plant and equipment. </context> | us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount |
During the years ended December 31, 2024, 2023 and 2022, we capitalized $ 77 million, $ 60 million and $ 46 million, respectively, of stock-based compensation expense as construction in progress in property, plant and equipment. | text | 60 | monetaryItemType | text: <entity> 60 </entity> <entity type> monetaryItemType </entity type> <context> During the years ended December 31, 2024, 2023 and 2022, we capitalized $ 77 million, $ 60 million and $ 46 million, respectively, of stock-based compensation expense as construction in progress in property, plant and equipment. </context> | us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount |
During the years ended December 31, 2024, 2023 and 2022, we capitalized $ 77 million, $ 60 million and $ 46 million, respectively, of stock-based compensation expense as construction in progress in property, plant and equipment. | text | 46 | monetaryItemType | text: <entity> 46 </entity> <entity type> monetaryItemType </entity type> <context> During the years ended December 31, 2024, 2023 and 2022, we capitalized $ 77 million, $ 60 million and $ 46 million, respectively, of stock-based compensation expense as construction in progress in property, plant and equipment. </context> | us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount |
As of December 31, 2024, the total stock-based compensation cost related to unvested equity awards not yet recognized, net of estimated forfeitures, totaled $ 850 million, which is expected to be recognized over a weighted-average period of 2.17 years. | text | 850 | monetaryItemType | text: <entity> 850 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the total stock-based compensation cost related to unvested equity awards not yet recognized, net of estimated forfeitures, totaled $ 850 million, which is expected to be recognized over a weighted-average period of 2.17 years. </context> | us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized |
As of December 31, 2024, we had tax credit carryforwards of $ 6 million, which expire if not utilized, from 2025 to 2031. We also had capital losses of $ 7 million, which can be carried forward indefinitely. | text | 6 | monetaryItemType | text: <entity> 6 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, we had tax credit carryforwards of $ 6 million, which expire if not utilized, from 2025 to 2031. We also had capital losses of $ 7 million, which can be carried forward indefinitely. </context> | us-gaap:TaxCreditCarryforwardAmount |
As of December 31, 2024, we had tax credit carryforwards of $ 6 million, which expire if not utilized, from 2025 to 2031. We also had capital losses of $ 7 million, which can be carried forward indefinitely. | text | 7 | monetaryItemType | text: <entity> 7 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, we had tax credit carryforwards of $ 6 million, which expire if not utilized, from 2025 to 2031. We also had capital losses of $ 7 million, which can be carried forward indefinitely. </context> | us-gaap:TaxCreditCarryforwardAmount |
We recognize interest and penalties related to unrecognized tax benefits within income tax expense in the consolidated statements of operations. We accrued $ 5 million, $ 7 million, and $ 7 million for interest and penalties as of December 31, 2024, 2023 and 2022, respectively. | text | 5 | monetaryItemType | text: <entity> 5 </entity> <entity type> monetaryItemType </entity type> <context> We recognize interest and penalties related to unrecognized tax benefits within income tax expense in the consolidated statements of operations. We accrued $ 5 million, $ 7 million, and $ 7 million for interest and penalties as of December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued |
We recognize interest and penalties related to unrecognized tax benefits within income tax expense in the consolidated statements of operations. We accrued $ 5 million, $ 7 million, and $ 7 million for interest and penalties as of December 31, 2024, 2023 and 2022, respectively. | text | 7 | monetaryItemType | text: <entity> 7 </entity> <entity type> monetaryItemType </entity type> <context> We recognize interest and penalties related to unrecognized tax benefits within income tax expense in the consolidated statements of operations. We accrued $ 5 million, $ 7 million, and $ 7 million for interest and penalties as of December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued |
The unrecognized tax benefits of $ 57 million as of December 31, 2024, if subsequently recognized, will affect our effective tax rate favorably at the time when such a benefit is recognized. | text | 57 | monetaryItemType | text: <entity> 57 </entity> <entity type> monetaryItemType </entity type> <context> The unrecognized tax benefits of $ 57 million as of December 31, 2024, if subsequently recognized, will affect our effective tax rate favorably at the time when such a benefit is recognized. </context> | us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate |
As a result of our various IBX data center expansion projects, as of December 31, 2024, we were contractually committed for approximately $ 2.9 billion of unaccrued capital expenditures, primarily for IBX infrastructure equipment not yet delivered and labor not yet provided, in connection with the work necessary to open these IBX data centers and make them available to our customers for installation. We also had numerous other, non-capital purchase commitments in place as of December 31, 2024, such as commitments to purchase power in select locations through 2025 and thereafter, and other open purchase orders for goods or services to be delivered or provided during 2025 and thereafter. Such other miscellaneous purchase commitments totaled approximately $ 2.1 billion as of December 31, 2024. For further information on our equity method investment commitments and lease commitments, see Note 5 and Note 9, respectively, above. | text | 2.9 | monetaryItemType | text: <entity> 2.9 </entity> <entity type> monetaryItemType </entity type> <context> As a result of our various IBX data center expansion projects, as of December 31, 2024, we were contractually committed for approximately $ 2.9 billion of unaccrued capital expenditures, primarily for IBX infrastructure equipment not yet delivered and labor not yet provided, in connection with the work necessary to open these IBX data centers and make them available to our customers for installation. We also had numerous other, non-capital purchase commitments in place as of December 31, 2024, such as commitments to purchase power in select locations through 2025 and thereafter, and other open purchase orders for goods or services to be delivered or provided during 2025 and thereafter. Such other miscellaneous purchase commitments totaled approximately $ 2.1 billion as of December 31, 2024. For further information on our equity method investment commitments and lease commitments, see Note 5 and Note 9, respectively, above. </context> | us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount |
As a result of our various IBX data center expansion projects, as of December 31, 2024, we were contractually committed for approximately $ 2.9 billion of unaccrued capital expenditures, primarily for IBX infrastructure equipment not yet delivered and labor not yet provided, in connection with the work necessary to open these IBX data centers and make them available to our customers for installation. We also had numerous other, non-capital purchase commitments in place as of December 31, 2024, such as commitments to purchase power in select locations through 2025 and thereafter, and other open purchase orders for goods or services to be delivered or provided during 2025 and thereafter. Such other miscellaneous purchase commitments totaled approximately $ 2.1 billion as of December 31, 2024. For further information on our equity method investment commitments and lease commitments, see Note 5 and Note 9, respectively, above. | text | 2.1 | monetaryItemType | text: <entity> 2.1 </entity> <entity type> monetaryItemType </entity type> <context> As a result of our various IBX data center expansion projects, as of December 31, 2024, we were contractually committed for approximately $ 2.9 billion of unaccrued capital expenditures, primarily for IBX infrastructure equipment not yet delivered and labor not yet provided, in connection with the work necessary to open these IBX data centers and make them available to our customers for installation. We also had numerous other, non-capital purchase commitments in place as of December 31, 2024, such as commitments to purchase power in select locations through 2025 and thereafter, and other open purchase orders for goods or services to be delivered or provided during 2025 and thereafter. Such other miscellaneous purchase commitments totaled approximately $ 2.1 billion as of December 31, 2024. For further information on our equity method investment commitments and lease commitments, see Note 5 and Note 9, respectively, above. </context> | us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount |
In the opinion of management, there are no other pending claims for which the outcome is expected to result in a material adverse effect in the financial position, results of operations or cash flows. | text | no | integerItemType | text: <entity> no </entity> <entity type> integerItemType </entity type> <context> In the opinion of management, there are no other pending claims for which the outcome is expected to result in a material adverse effect in the financial position, results of operations or cash flows. </context> | us-gaap:LossContingencyPendingClaimsNumber |
result, our estimated fair value of these agreements is minimal. We do not have significant liabilities recorded for these agreements as of December 31, 2024. | text | not | monetaryItemType | text: <entity> not </entity> <entity type> monetaryItemType </entity type> <context> result, our estimated fair value of these agreements is minimal. We do not have significant liabilities recorded for these agreements as of December 31, 2024. </context> | us-gaap:GuaranteeObligationsCurrentCarryingValue |
We have service level commitment obligations to certain of our customers. As a result, service interruptions or significant equipment damage in our IBX data centers, whether or not within our control, could result in obligations to these customers. While we have purchased insurance that could limit our exposure, our liability insurance may not be adequate to cover those expenses. In addition, any loss of service, equipment damage or inability to meet our service level commitment obligations could reduce the confidence our customers have in us, and could consequently impair our ability to obtain and retain customers, which would adversely affect both our ability to generate revenues and our operating results. We generally have the ability to determine such service level credits prior to the associated revenue being recognized. We do no t have significant liabilities in connection with service level credits as of December 31, 2024. | text | no | monetaryItemType | text: <entity> no </entity> <entity type> monetaryItemType </entity type> <context> We have service level commitment obligations to certain of our customers. As a result, service interruptions or significant equipment damage in our IBX data centers, whether or not within our control, could result in obligations to these customers. While we have purchased insurance that could limit our exposure, our liability insurance may not be adequate to cover those expenses. In addition, any loss of service, equipment damage or inability to meet our service level commitment obligations could reduce the confidence our customers have in us, and could consequently impair our ability to obtain and retain customers, which would adversely affect both our ability to generate revenues and our operating results. We generally have the ability to determine such service level credits prior to the associated revenue being recognized. We do no t have significant liabilities in connection with service level credits as of December 31, 2024. </context> | us-gaap:GuaranteeObligationsCurrentCarryingValue |
Concurrent with the closing of the AMER 2 Joint Venture, we entered into a loan agreement (the "AMER 2 Loan") with the AMER 2 Joint Venture, as a lender, with a maximum commitment of $ 392 million and a maturity date of April 10, 2028. We received an upfront fee of $ 4 million in connection with the origination of the loan, and earn interest at a contractual rate of 10 % per annum on the drawn portion plus an unused commitment fee of 0.75 % per annum on the undrawn portion, each payable quarterly. The term of the loan may be extended at the option of the borrower for one additional year subject to an extension fee, and may be prepaid subject to a penalty if such prepayment occurs within the first 18 months of issuance. The AMER 2 Loan is secured by the assets of the AMER 2 Joint Venture, including the SV12 data center site. The equity partners of the AMER 2 Joint Venture have provided limited guarantees in connection with the AMER 2 Loan, which require payments to the lender proportionately upon certain occurrences, such as a shortfall in capital necessary to complete construction or to make interest payments. Additionally, the equity partners may be liable for repayment of up to the entire debt balance upon the occurrence of certain adverse acts such as a non-permitted transfer of the SV12 data center site. The AMER 2 Loan was negotiated at arm's length. We have assessed the credit risk associated with the AMER 2 Loan to be low and the allowance for credit loss as of December 31, 2024 is insignificant. The maximum amount of credit loss we are exposed to is the outstanding principal, plus accrued interest and unused commitment fees. As of December 31, 2024, the total amount outstanding under the AMER 2 Loan, net of the unamortized upfront fee, was $ 258 million. Additional amounts may be drawn down by the borrower periodically as needed for the continuation of development and other working capital needs. | text | 392 | monetaryItemType | text: <entity> 392 </entity> <entity type> monetaryItemType </entity type> <context> Concurrent with the closing of the AMER 2 Joint Venture, we entered into a loan agreement (the "AMER 2 Loan") with the AMER 2 Joint Venture, as a lender, with a maximum commitment of $ 392 million and a maturity date of April 10, 2028. We received an upfront fee of $ 4 million in connection with the origination of the loan, and earn interest at a contractual rate of 10 % per annum on the drawn portion plus an unused commitment fee of 0.75 % per annum on the undrawn portion, each payable quarterly. The term of the loan may be extended at the option of the borrower for one additional year subject to an extension fee, and may be prepaid subject to a penalty if such prepayment occurs within the first 18 months of issuance. The AMER 2 Loan is secured by the assets of the AMER 2 Joint Venture, including the SV12 data center site. The equity partners of the AMER 2 Joint Venture have provided limited guarantees in connection with the AMER 2 Loan, which require payments to the lender proportionately upon certain occurrences, such as a shortfall in capital necessary to complete construction or to make interest payments. Additionally, the equity partners may be liable for repayment of up to the entire debt balance upon the occurrence of certain adverse acts such as a non-permitted transfer of the SV12 data center site. The AMER 2 Loan was negotiated at arm's length. We have assessed the credit risk associated with the AMER 2 Loan to be low and the allowance for credit loss as of December 31, 2024 is insignificant. The maximum amount of credit loss we are exposed to is the outstanding principal, plus accrued interest and unused commitment fees. As of December 31, 2024, the total amount outstanding under the AMER 2 Loan, net of the unamortized upfront fee, was $ 258 million. Additional amounts may be drawn down by the borrower periodically as needed for the continuation of development and other working capital needs. </context> | us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity |
Concurrent with the closing of the AMER 2 Joint Venture, we entered into a loan agreement (the "AMER 2 Loan") with the AMER 2 Joint Venture, as a lender, with a maximum commitment of $ 392 million and a maturity date of April 10, 2028. We received an upfront fee of $ 4 million in connection with the origination of the loan, and earn interest at a contractual rate of 10 % per annum on the drawn portion plus an unused commitment fee of 0.75 % per annum on the undrawn portion, each payable quarterly. The term of the loan may be extended at the option of the borrower for one additional year subject to an extension fee, and may be prepaid subject to a penalty if such prepayment occurs within the first 18 months of issuance. The AMER 2 Loan is secured by the assets of the AMER 2 Joint Venture, including the SV12 data center site. The equity partners of the AMER 2 Joint Venture have provided limited guarantees in connection with the AMER 2 Loan, which require payments to the lender proportionately upon certain occurrences, such as a shortfall in capital necessary to complete construction or to make interest payments. Additionally, the equity partners may be liable for repayment of up to the entire debt balance upon the occurrence of certain adverse acts such as a non-permitted transfer of the SV12 data center site. The AMER 2 Loan was negotiated at arm's length. We have assessed the credit risk associated with the AMER 2 Loan to be low and the allowance for credit loss as of December 31, 2024 is insignificant. The maximum amount of credit loss we are exposed to is the outstanding principal, plus accrued interest and unused commitment fees. As of December 31, 2024, the total amount outstanding under the AMER 2 Loan, net of the unamortized upfront fee, was $ 258 million. Additional amounts may be drawn down by the borrower periodically as needed for the continuation of development and other working capital needs. | text | 10 | percentItemType | text: <entity> 10 </entity> <entity type> percentItemType </entity type> <context> Concurrent with the closing of the AMER 2 Joint Venture, we entered into a loan agreement (the "AMER 2 Loan") with the AMER 2 Joint Venture, as a lender, with a maximum commitment of $ 392 million and a maturity date of April 10, 2028. We received an upfront fee of $ 4 million in connection with the origination of the loan, and earn interest at a contractual rate of 10 % per annum on the drawn portion plus an unused commitment fee of 0.75 % per annum on the undrawn portion, each payable quarterly. The term of the loan may be extended at the option of the borrower for one additional year subject to an extension fee, and may be prepaid subject to a penalty if such prepayment occurs within the first 18 months of issuance. The AMER 2 Loan is secured by the assets of the AMER 2 Joint Venture, including the SV12 data center site. The equity partners of the AMER 2 Joint Venture have provided limited guarantees in connection with the AMER 2 Loan, which require payments to the lender proportionately upon certain occurrences, such as a shortfall in capital necessary to complete construction or to make interest payments. Additionally, the equity partners may be liable for repayment of up to the entire debt balance upon the occurrence of certain adverse acts such as a non-permitted transfer of the SV12 data center site. The AMER 2 Loan was negotiated at arm's length. We have assessed the credit risk associated with the AMER 2 Loan to be low and the allowance for credit loss as of December 31, 2024 is insignificant. The maximum amount of credit loss we are exposed to is the outstanding principal, plus accrued interest and unused commitment fees. As of December 31, 2024, the total amount outstanding under the AMER 2 Loan, net of the unamortized upfront fee, was $ 258 million. Additional amounts may be drawn down by the borrower periodically as needed for the continuation of development and other working capital needs. </context> | us-gaap:DebtInstrumentInterestRateEffectivePercentage |
Concurrent with the closing of the AMER 2 Joint Venture, we entered into a loan agreement (the "AMER 2 Loan") with the AMER 2 Joint Venture, as a lender, with a maximum commitment of $ 392 million and a maturity date of April 10, 2028. We received an upfront fee of $ 4 million in connection with the origination of the loan, and earn interest at a contractual rate of 10 % per annum on the drawn portion plus an unused commitment fee of 0.75 % per annum on the undrawn portion, each payable quarterly. The term of the loan may be extended at the option of the borrower for one additional year subject to an extension fee, and may be prepaid subject to a penalty if such prepayment occurs within the first 18 months of issuance. The AMER 2 Loan is secured by the assets of the AMER 2 Joint Venture, including the SV12 data center site. The equity partners of the AMER 2 Joint Venture have provided limited guarantees in connection with the AMER 2 Loan, which require payments to the lender proportionately upon certain occurrences, such as a shortfall in capital necessary to complete construction or to make interest payments. Additionally, the equity partners may be liable for repayment of up to the entire debt balance upon the occurrence of certain adverse acts such as a non-permitted transfer of the SV12 data center site. The AMER 2 Loan was negotiated at arm's length. We have assessed the credit risk associated with the AMER 2 Loan to be low and the allowance for credit loss as of December 31, 2024 is insignificant. The maximum amount of credit loss we are exposed to is the outstanding principal, plus accrued interest and unused commitment fees. As of December 31, 2024, the total amount outstanding under the AMER 2 Loan, net of the unamortized upfront fee, was $ 258 million. Additional amounts may be drawn down by the borrower periodically as needed for the continuation of development and other working capital needs. | text | 0.75 | percentItemType | text: <entity> 0.75 </entity> <entity type> percentItemType </entity type> <context> Concurrent with the closing of the AMER 2 Joint Venture, we entered into a loan agreement (the "AMER 2 Loan") with the AMER 2 Joint Venture, as a lender, with a maximum commitment of $ 392 million and a maturity date of April 10, 2028. We received an upfront fee of $ 4 million in connection with the origination of the loan, and earn interest at a contractual rate of 10 % per annum on the drawn portion plus an unused commitment fee of 0.75 % per annum on the undrawn portion, each payable quarterly. The term of the loan may be extended at the option of the borrower for one additional year subject to an extension fee, and may be prepaid subject to a penalty if such prepayment occurs within the first 18 months of issuance. The AMER 2 Loan is secured by the assets of the AMER 2 Joint Venture, including the SV12 data center site. The equity partners of the AMER 2 Joint Venture have provided limited guarantees in connection with the AMER 2 Loan, which require payments to the lender proportionately upon certain occurrences, such as a shortfall in capital necessary to complete construction or to make interest payments. Additionally, the equity partners may be liable for repayment of up to the entire debt balance upon the occurrence of certain adverse acts such as a non-permitted transfer of the SV12 data center site. The AMER 2 Loan was negotiated at arm's length. We have assessed the credit risk associated with the AMER 2 Loan to be low and the allowance for credit loss as of December 31, 2024 is insignificant. The maximum amount of credit loss we are exposed to is the outstanding principal, plus accrued interest and unused commitment fees. As of December 31, 2024, the total amount outstanding under the AMER 2 Loan, net of the unamortized upfront fee, was $ 258 million. Additional amounts may be drawn down by the borrower periodically as needed for the continuation of development and other working capital needs. </context> | us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage |
Concurrent with the closing of the AMER 2 Joint Venture, we entered into a loan agreement (the "AMER 2 Loan") with the AMER 2 Joint Venture, as a lender, with a maximum commitment of $ 392 million and a maturity date of April 10, 2028. We received an upfront fee of $ 4 million in connection with the origination of the loan, and earn interest at a contractual rate of 10 % per annum on the drawn portion plus an unused commitment fee of 0.75 % per annum on the undrawn portion, each payable quarterly. The term of the loan may be extended at the option of the borrower for one additional year subject to an extension fee, and may be prepaid subject to a penalty if such prepayment occurs within the first 18 months of issuance. The AMER 2 Loan is secured by the assets of the AMER 2 Joint Venture, including the SV12 data center site. The equity partners of the AMER 2 Joint Venture have provided limited guarantees in connection with the AMER 2 Loan, which require payments to the lender proportionately upon certain occurrences, such as a shortfall in capital necessary to complete construction or to make interest payments. Additionally, the equity partners may be liable for repayment of up to the entire debt balance upon the occurrence of certain adverse acts such as a non-permitted transfer of the SV12 data center site. The AMER 2 Loan was negotiated at arm's length. We have assessed the credit risk associated with the AMER 2 Loan to be low and the allowance for credit loss as of December 31, 2024 is insignificant. The maximum amount of credit loss we are exposed to is the outstanding principal, plus accrued interest and unused commitment fees. As of December 31, 2024, the total amount outstanding under the AMER 2 Loan, net of the unamortized upfront fee, was $ 258 million. Additional amounts may be drawn down by the borrower periodically as needed for the continuation of development and other working capital needs. | text | 258 | monetaryItemType | text: <entity> 258 </entity> <entity type> monetaryItemType </entity type> <context> Concurrent with the closing of the AMER 2 Joint Venture, we entered into a loan agreement (the "AMER 2 Loan") with the AMER 2 Joint Venture, as a lender, with a maximum commitment of $ 392 million and a maturity date of April 10, 2028. We received an upfront fee of $ 4 million in connection with the origination of the loan, and earn interest at a contractual rate of 10 % per annum on the drawn portion plus an unused commitment fee of 0.75 % per annum on the undrawn portion, each payable quarterly. The term of the loan may be extended at the option of the borrower for one additional year subject to an extension fee, and may be prepaid subject to a penalty if such prepayment occurs within the first 18 months of issuance. The AMER 2 Loan is secured by the assets of the AMER 2 Joint Venture, including the SV12 data center site. The equity partners of the AMER 2 Joint Venture have provided limited guarantees in connection with the AMER 2 Loan, which require payments to the lender proportionately upon certain occurrences, such as a shortfall in capital necessary to complete construction or to make interest payments. Additionally, the equity partners may be liable for repayment of up to the entire debt balance upon the occurrence of certain adverse acts such as a non-permitted transfer of the SV12 data center site. The AMER 2 Loan was negotiated at arm's length. We have assessed the credit risk associated with the AMER 2 Loan to be low and the allowance for credit loss as of December 31, 2024 is insignificant. The maximum amount of credit loss we are exposed to is the outstanding principal, plus accrued interest and unused commitment fees. As of December 31, 2024, the total amount outstanding under the AMER 2 Loan, net of the unamortized upfront fee, was $ 258 million. Additional amounts may be drawn down by the borrower periodically as needed for the continuation of development and other working capital needs. </context> | us-gaap:LineOfCredit |
Primarily consists of revenues related to lease and services arrangements as described above and also includes interest income earned on the AMER 2 Loan for the year ended December 31, 2024 of $ 17 million. | text | 17 | monetaryItemType | text: <entity> 17 </entity> <entity type> monetaryItemType </entity type> <context> Primarily consists of revenues related to lease and services arrangements as described above and also includes interest income earned on the AMER 2 Loan for the year ended December 31, 2024 of $ 17 million. </context> | us-gaap:InterestIncomeOther |
In November 2024, we initiated a restructuring plan to realign the organization and enable further investment in key priority areas (the "Q4 2024 Restructuring Plan"), resulting in costs of $ 27 million being incurred during the year ended December 31, 2024. The activities under the Q4 2024 Restructuring Plan were substantially completed by December 31, 2024. | text | 27 | monetaryItemType | text: <entity> 27 </entity> <entity type> monetaryItemType </entity type> <context> In November 2024, we initiated a restructuring plan to realign the organization and enable further investment in key priority areas (the "Q4 2024 Restructuring Plan"), resulting in costs of $ 27 million being incurred during the year ended December 31, 2024. The activities under the Q4 2024 Restructuring Plan were substantially completed by December 31, 2024. </context> | us-gaap:RestructuringAndRelatedCostIncurredCost |
In November 2024, we announced the decision to make Equinix Metal no longer commercially available as a product and to wind down operations that support this product by June 2026 (the "Equinix Metal Wind Down"). As a result of the Equinix Metal Wind Down, we expect to incur costs of approximately $ 10 million to $ 14 million, with $ 4 million of these costs incurred during the year ended December 31, 2024. We expect substantially all costs under this plan to be incurred and paid by the end of the fourth quarter of 2026. The actual amounts and timing of incremental costs and cash payments may differ from these estimates should we make further decisions which impact the execution of these activities. In addition, we recorded an impairment charge of $ 160 million associated with the Equinix Metal Wind Down during the year ended December 31, 2024, as described in Note 17. | text | 10 | monetaryItemType | text: <entity> 10 </entity> <entity type> monetaryItemType </entity type> <context> In November 2024, we announced the decision to make Equinix Metal no longer commercially available as a product and to wind down operations that support this product by June 2026 (the "Equinix Metal Wind Down"). As a result of the Equinix Metal Wind Down, we expect to incur costs of approximately $ 10 million to $ 14 million, with $ 4 million of these costs incurred during the year ended December 31, 2024. We expect substantially all costs under this plan to be incurred and paid by the end of the fourth quarter of 2026. The actual amounts and timing of incremental costs and cash payments may differ from these estimates should we make further decisions which impact the execution of these activities. In addition, we recorded an impairment charge of $ 160 million associated with the Equinix Metal Wind Down during the year ended December 31, 2024, as described in Note 17. </context> | us-gaap:RestructuringAndRelatedCostExpectedCost1 |
In November 2024, we announced the decision to make Equinix Metal no longer commercially available as a product and to wind down operations that support this product by June 2026 (the "Equinix Metal Wind Down"). As a result of the Equinix Metal Wind Down, we expect to incur costs of approximately $ 10 million to $ 14 million, with $ 4 million of these costs incurred during the year ended December 31, 2024. We expect substantially all costs under this plan to be incurred and paid by the end of the fourth quarter of 2026. The actual amounts and timing of incremental costs and cash payments may differ from these estimates should we make further decisions which impact the execution of these activities. In addition, we recorded an impairment charge of $ 160 million associated with the Equinix Metal Wind Down during the year ended December 31, 2024, as described in Note 17. | text | 14 | monetaryItemType | text: <entity> 14 </entity> <entity type> monetaryItemType </entity type> <context> In November 2024, we announced the decision to make Equinix Metal no longer commercially available as a product and to wind down operations that support this product by June 2026 (the "Equinix Metal Wind Down"). As a result of the Equinix Metal Wind Down, we expect to incur costs of approximately $ 10 million to $ 14 million, with $ 4 million of these costs incurred during the year ended December 31, 2024. We expect substantially all costs under this plan to be incurred and paid by the end of the fourth quarter of 2026. The actual amounts and timing of incremental costs and cash payments may differ from these estimates should we make further decisions which impact the execution of these activities. In addition, we recorded an impairment charge of $ 160 million associated with the Equinix Metal Wind Down during the year ended December 31, 2024, as described in Note 17. </context> | us-gaap:RestructuringAndRelatedCostExpectedCost1 |
In November 2024, we announced the decision to make Equinix Metal no longer commercially available as a product and to wind down operations that support this product by June 2026 (the "Equinix Metal Wind Down"). As a result of the Equinix Metal Wind Down, we expect to incur costs of approximately $ 10 million to $ 14 million, with $ 4 million of these costs incurred during the year ended December 31, 2024. We expect substantially all costs under this plan to be incurred and paid by the end of the fourth quarter of 2026. The actual amounts and timing of incremental costs and cash payments may differ from these estimates should we make further decisions which impact the execution of these activities. In addition, we recorded an impairment charge of $ 160 million associated with the Equinix Metal Wind Down during the year ended December 31, 2024, as described in Note 17. | text | 4 | monetaryItemType | text: <entity> 4 </entity> <entity type> monetaryItemType </entity type> <context> In November 2024, we announced the decision to make Equinix Metal no longer commercially available as a product and to wind down operations that support this product by June 2026 (the "Equinix Metal Wind Down"). As a result of the Equinix Metal Wind Down, we expect to incur costs of approximately $ 10 million to $ 14 million, with $ 4 million of these costs incurred during the year ended December 31, 2024. We expect substantially all costs under this plan to be incurred and paid by the end of the fourth quarter of 2026. The actual amounts and timing of incremental costs and cash payments may differ from these estimates should we make further decisions which impact the execution of these activities. In addition, we recorded an impairment charge of $ 160 million associated with the Equinix Metal Wind Down during the year ended December 31, 2024, as described in Note 17. </context> | us-gaap:RestructuringAndRelatedCostIncurredCost |
In November 2024, we announced the decision to make Equinix Metal no longer commercially available as a product and to wind down operations that support this product by June 2026 (the "Equinix Metal Wind Down"). As a result of the Equinix Metal Wind Down, we expect to incur costs of approximately $ 10 million to $ 14 million, with $ 4 million of these costs incurred during the year ended December 31, 2024. We expect substantially all costs under this plan to be incurred and paid by the end of the fourth quarter of 2026. The actual amounts and timing of incremental costs and cash payments may differ from these estimates should we make further decisions which impact the execution of these activities. In addition, we recorded an impairment charge of $ 160 million associated with the Equinix Metal Wind Down during the year ended December 31, 2024, as described in Note 17. | text | 160 | monetaryItemType | text: <entity> 160 </entity> <entity type> monetaryItemType </entity type> <context> In November 2024, we announced the decision to make Equinix Metal no longer commercially available as a product and to wind down operations that support this product by June 2026 (the "Equinix Metal Wind Down"). As a result of the Equinix Metal Wind Down, we expect to incur costs of approximately $ 10 million to $ 14 million, with $ 4 million of these costs incurred during the year ended December 31, 2024. We expect substantially all costs under this plan to be incurred and paid by the end of the fourth quarter of 2026. The actual amounts and timing of incremental costs and cash payments may differ from these estimates should we make further decisions which impact the execution of these activities. In addition, we recorded an impairment charge of $ 160 million associated with the Equinix Metal Wind Down during the year ended December 31, 2024, as described in Note 17. </context> | us-gaap:RestructuringCostsAndAssetImpairmentCharges |
Total restructuring charges were incurred in each of our three regions with $ 21 million in the Americas, $ 6 million in EMEA and $ 4 million in Asia-Pacific. | text | 21 | monetaryItemType | text: <entity> 21 </entity> <entity type> monetaryItemType </entity type> <context> Total restructuring charges were incurred in each of our three regions with $ 21 million in the Americas, $ 6 million in EMEA and $ 4 million in Asia-Pacific. </context> | us-gaap:RestructuringAndRelatedCostIncurredCost |
Total restructuring charges were incurred in each of our three regions with $ 21 million in the Americas, $ 6 million in EMEA and $ 4 million in Asia-Pacific. | text | 6 | monetaryItemType | text: <entity> 6 </entity> <entity type> monetaryItemType </entity type> <context> Total restructuring charges were incurred in each of our three regions with $ 21 million in the Americas, $ 6 million in EMEA and $ 4 million in Asia-Pacific. </context> | us-gaap:RestructuringAndRelatedCostIncurredCost |
Total restructuring charges were incurred in each of our three regions with $ 21 million in the Americas, $ 6 million in EMEA and $ 4 million in Asia-Pacific. | text | 4 | monetaryItemType | text: <entity> 4 </entity> <entity type> monetaryItemType </entity type> <context> Total restructuring charges were incurred in each of our three regions with $ 21 million in the Americas, $ 6 million in EMEA and $ 4 million in Asia-Pacific. </context> | us-gaap:RestructuringAndRelatedCostIncurredCost |
During the fourth quarter of 2024, we identified an indicator that certain assets supporting the sale of our Equinix Metal products may be impaired due to the Equinix Metal Wind Down as described in Note 16. We evaluated the fair value of the asset group, which consisted primarily of hardware, internal-use software, and customer relationships, by determining the fair value in exchange for each class of assets and determined that the carrying amount exceeded the fair value. The significant inputs and assumptions used in the estimate of fair value include broker estimates and liquidation value assumptions. These measurements were classified within Level 3 of the fair value hierarchy as they are not observable. We recorded impairment charges of $ 131 million and $ 29 million on property, plant and equipment and intangible assets, respectively, during the fourth quarter of 2024. These impairment charges were recorded in each of our three regions with $ 127 million in the Americas, $ 19 million in EMEA and $ 14 million in Asia-Pacific. | text | 131 | monetaryItemType | text: <entity> 131 </entity> <entity type> monetaryItemType </entity type> <context> During the fourth quarter of 2024, we identified an indicator that certain assets supporting the sale of our Equinix Metal products may be impaired due to the Equinix Metal Wind Down as described in Note 16. We evaluated the fair value of the asset group, which consisted primarily of hardware, internal-use software, and customer relationships, by determining the fair value in exchange for each class of assets and determined that the carrying amount exceeded the fair value. The significant inputs and assumptions used in the estimate of fair value include broker estimates and liquidation value assumptions. These measurements were classified within Level 3 of the fair value hierarchy as they are not observable. We recorded impairment charges of $ 131 million and $ 29 million on property, plant and equipment and intangible assets, respectively, during the fourth quarter of 2024. These impairment charges were recorded in each of our three regions with $ 127 million in the Americas, $ 19 million in EMEA and $ 14 million in Asia-Pacific. </context> | us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf |
During the fourth quarter of 2024, we identified an indicator that certain assets supporting the sale of our Equinix Metal products may be impaired due to the Equinix Metal Wind Down as described in Note 16. We evaluated the fair value of the asset group, which consisted primarily of hardware, internal-use software, and customer relationships, by determining the fair value in exchange for each class of assets and determined that the carrying amount exceeded the fair value. The significant inputs and assumptions used in the estimate of fair value include broker estimates and liquidation value assumptions. These measurements were classified within Level 3 of the fair value hierarchy as they are not observable. We recorded impairment charges of $ 131 million and $ 29 million on property, plant and equipment and intangible assets, respectively, during the fourth quarter of 2024. These impairment charges were recorded in each of our three regions with $ 127 million in the Americas, $ 19 million in EMEA and $ 14 million in Asia-Pacific. | text | 29 | monetaryItemType | text: <entity> 29 </entity> <entity type> monetaryItemType </entity type> <context> During the fourth quarter of 2024, we identified an indicator that certain assets supporting the sale of our Equinix Metal products may be impaired due to the Equinix Metal Wind Down as described in Note 16. We evaluated the fair value of the asset group, which consisted primarily of hardware, internal-use software, and customer relationships, by determining the fair value in exchange for each class of assets and determined that the carrying amount exceeded the fair value. The significant inputs and assumptions used in the estimate of fair value include broker estimates and liquidation value assumptions. These measurements were classified within Level 3 of the fair value hierarchy as they are not observable. We recorded impairment charges of $ 131 million and $ 29 million on property, plant and equipment and intangible assets, respectively, during the fourth quarter of 2024. These impairment charges were recorded in each of our three regions with $ 127 million in the Americas, $ 19 million in EMEA and $ 14 million in Asia-Pacific. </context> | us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill |
During the fourth quarter of 2024, we identified an indicator that certain assets supporting the sale of our Equinix Metal products may be impaired due to the Equinix Metal Wind Down as described in Note 16. We evaluated the fair value of the asset group, which consisted primarily of hardware, internal-use software, and customer relationships, by determining the fair value in exchange for each class of assets and determined that the carrying amount exceeded the fair value. The significant inputs and assumptions used in the estimate of fair value include broker estimates and liquidation value assumptions. These measurements were classified within Level 3 of the fair value hierarchy as they are not observable. We recorded impairment charges of $ 131 million and $ 29 million on property, plant and equipment and intangible assets, respectively, during the fourth quarter of 2024. These impairment charges were recorded in each of our three regions with $ 127 million in the Americas, $ 19 million in EMEA and $ 14 million in Asia-Pacific. | text | 127 | monetaryItemType | text: <entity> 127 </entity> <entity type> monetaryItemType </entity type> <context> During the fourth quarter of 2024, we identified an indicator that certain assets supporting the sale of our Equinix Metal products may be impaired due to the Equinix Metal Wind Down as described in Note 16. We evaluated the fair value of the asset group, which consisted primarily of hardware, internal-use software, and customer relationships, by determining the fair value in exchange for each class of assets and determined that the carrying amount exceeded the fair value. The significant inputs and assumptions used in the estimate of fair value include broker estimates and liquidation value assumptions. These measurements were classified within Level 3 of the fair value hierarchy as they are not observable. We recorded impairment charges of $ 131 million and $ 29 million on property, plant and equipment and intangible assets, respectively, during the fourth quarter of 2024. These impairment charges were recorded in each of our three regions with $ 127 million in the Americas, $ 19 million in EMEA and $ 14 million in Asia-Pacific. </context> | us-gaap:AssetImpairmentCharges |
During the fourth quarter of 2024, we identified an indicator that certain assets supporting the sale of our Equinix Metal products may be impaired due to the Equinix Metal Wind Down as described in Note 16. We evaluated the fair value of the asset group, which consisted primarily of hardware, internal-use software, and customer relationships, by determining the fair value in exchange for each class of assets and determined that the carrying amount exceeded the fair value. The significant inputs and assumptions used in the estimate of fair value include broker estimates and liquidation value assumptions. These measurements were classified within Level 3 of the fair value hierarchy as they are not observable. We recorded impairment charges of $ 131 million and $ 29 million on property, plant and equipment and intangible assets, respectively, during the fourth quarter of 2024. These impairment charges were recorded in each of our three regions with $ 127 million in the Americas, $ 19 million in EMEA and $ 14 million in Asia-Pacific. | text | 19 | monetaryItemType | text: <entity> 19 </entity> <entity type> monetaryItemType </entity type> <context> During the fourth quarter of 2024, we identified an indicator that certain assets supporting the sale of our Equinix Metal products may be impaired due to the Equinix Metal Wind Down as described in Note 16. We evaluated the fair value of the asset group, which consisted primarily of hardware, internal-use software, and customer relationships, by determining the fair value in exchange for each class of assets and determined that the carrying amount exceeded the fair value. The significant inputs and assumptions used in the estimate of fair value include broker estimates and liquidation value assumptions. These measurements were classified within Level 3 of the fair value hierarchy as they are not observable. We recorded impairment charges of $ 131 million and $ 29 million on property, plant and equipment and intangible assets, respectively, during the fourth quarter of 2024. These impairment charges were recorded in each of our three regions with $ 127 million in the Americas, $ 19 million in EMEA and $ 14 million in Asia-Pacific. </context> | us-gaap:AssetImpairmentCharges |
During the fourth quarter of 2024, we identified an indicator that certain assets supporting the sale of our Equinix Metal products may be impaired due to the Equinix Metal Wind Down as described in Note 16. We evaluated the fair value of the asset group, which consisted primarily of hardware, internal-use software, and customer relationships, by determining the fair value in exchange for each class of assets and determined that the carrying amount exceeded the fair value. The significant inputs and assumptions used in the estimate of fair value include broker estimates and liquidation value assumptions. These measurements were classified within Level 3 of the fair value hierarchy as they are not observable. We recorded impairment charges of $ 131 million and $ 29 million on property, plant and equipment and intangible assets, respectively, during the fourth quarter of 2024. These impairment charges were recorded in each of our three regions with $ 127 million in the Americas, $ 19 million in EMEA and $ 14 million in Asia-Pacific. | text | 14 | monetaryItemType | text: <entity> 14 </entity> <entity type> monetaryItemType </entity type> <context> During the fourth quarter of 2024, we identified an indicator that certain assets supporting the sale of our Equinix Metal products may be impaired due to the Equinix Metal Wind Down as described in Note 16. We evaluated the fair value of the asset group, which consisted primarily of hardware, internal-use software, and customer relationships, by determining the fair value in exchange for each class of assets and determined that the carrying amount exceeded the fair value. The significant inputs and assumptions used in the estimate of fair value include broker estimates and liquidation value assumptions. These measurements were classified within Level 3 of the fair value hierarchy as they are not observable. We recorded impairment charges of $ 131 million and $ 29 million on property, plant and equipment and intangible assets, respectively, during the fourth quarter of 2024. These impairment charges were recorded in each of our three regions with $ 127 million in the Americas, $ 19 million in EMEA and $ 14 million in Asia-Pacific. </context> | us-gaap:AssetImpairmentCharges |
During the fourth quarter of 2024, we identified an indicator that an IBX asset group in the Asia-Pacific region may be impaired due to current and projected future losses at the site. We evaluated the fair value of the asset group, which consisted primarily of operating lease right-of-use assets, leasehold improvements, and personal property, and determined that the carrying amount exceeded the fair value. The fair value of the right-of-use assets were determined using the income approach. The significant inputs and assumptions used in the estimates of fair value include market rent and sublease rental adjustments. The fair values of the leasehold improvements and personal property were determined based on their fair values in exchange. The significant inputs and assumptions used in the estimate of fair value include broker estimates and liquidation value assumptions. These measurements were classified within Level 3 of the fair value hierarchy as they are not observable. We recorded impairment charges of $ 38 million and $ 35 million on operating lease right-of-use assets and property, plant and equipment, respectively, in the Asia-Pacific region during the fourth quarter of 2024. | text | 38 | monetaryItemType | text: <entity> 38 </entity> <entity type> monetaryItemType </entity type> <context> During the fourth quarter of 2024, we identified an indicator that an IBX asset group in the Asia-Pacific region may be impaired due to current and projected future losses at the site. We evaluated the fair value of the asset group, which consisted primarily of operating lease right-of-use assets, leasehold improvements, and personal property, and determined that the carrying amount exceeded the fair value. The fair value of the right-of-use assets were determined using the income approach. The significant inputs and assumptions used in the estimates of fair value include market rent and sublease rental adjustments. The fair values of the leasehold improvements and personal property were determined based on their fair values in exchange. The significant inputs and assumptions used in the estimate of fair value include broker estimates and liquidation value assumptions. These measurements were classified within Level 3 of the fair value hierarchy as they are not observable. We recorded impairment charges of $ 38 million and $ 35 million on operating lease right-of-use assets and property, plant and equipment, respectively, in the Asia-Pacific region during the fourth quarter of 2024. </context> | us-gaap:OperatingLeaseImpairmentLoss |
During the fourth quarter of 2024, we identified an indicator that an IBX asset group in the Asia-Pacific region may be impaired due to current and projected future losses at the site. We evaluated the fair value of the asset group, which consisted primarily of operating lease right-of-use assets, leasehold improvements, and personal property, and determined that the carrying amount exceeded the fair value. The fair value of the right-of-use assets were determined using the income approach. The significant inputs and assumptions used in the estimates of fair value include market rent and sublease rental adjustments. The fair values of the leasehold improvements and personal property were determined based on their fair values in exchange. The significant inputs and assumptions used in the estimate of fair value include broker estimates and liquidation value assumptions. These measurements were classified within Level 3 of the fair value hierarchy as they are not observable. We recorded impairment charges of $ 38 million and $ 35 million on operating lease right-of-use assets and property, plant and equipment, respectively, in the Asia-Pacific region during the fourth quarter of 2024. | text | 35 | monetaryItemType | text: <entity> 35 </entity> <entity type> monetaryItemType </entity type> <context> During the fourth quarter of 2024, we identified an indicator that an IBX asset group in the Asia-Pacific region may be impaired due to current and projected future losses at the site. We evaluated the fair value of the asset group, which consisted primarily of operating lease right-of-use assets, leasehold improvements, and personal property, and determined that the carrying amount exceeded the fair value. The fair value of the right-of-use assets were determined using the income approach. The significant inputs and assumptions used in the estimates of fair value include market rent and sublease rental adjustments. The fair values of the leasehold improvements and personal property were determined based on their fair values in exchange. The significant inputs and assumptions used in the estimate of fair value include broker estimates and liquidation value assumptions. These measurements were classified within Level 3 of the fair value hierarchy as they are not observable. We recorded impairment charges of $ 38 million and $ 35 million on operating lease right-of-use assets and property, plant and equipment, respectively, in the Asia-Pacific region during the fourth quarter of 2024. </context> | us-gaap:ImpairmentOfLongLivedAssetsHeldForUse |
While we have one primary line of business, which is the design, build-out and operation of IBX data centers, we have determined that we have three reportable segments comprised of our Americas, EMEA and Asia-Pacific geographic regions. Each of our three reportable segments are managed by regional presidents and require unique strategies due to the varying microeconomic and macroeconomic conditions within each region. Our chief executive officer is our chief operating decision maker and evaluates performance, makes operating decisions and allocates resources primarily based on our revenues and adjusted EBITDA, both on a consolidated basis and for these three reportable segments. Intercompany transactions between segments are excluded for management reporting purposes. | text | three | integerItemType | text: <entity> three </entity> <entity type> integerItemType </entity type> <context> While we have one primary line of business, which is the design, build-out and operation of IBX data centers, we have determined that we have three reportable segments comprised of our Americas, EMEA and Asia-Pacific geographic regions. Each of our three reportable segments are managed by regional presidents and require unique strategies due to the varying microeconomic and macroeconomic conditions within each region. Our chief executive officer is our chief operating decision maker and evaluates performance, makes operating decisions and allocates resources primarily based on our revenues and adjusted EBITDA, both on a consolidated basis and for these three reportable segments. Intercompany transactions between segments are excluded for management reporting purposes. </context> | us-gaap:NumberOfReportableSegments |
We define adjusted EBITDA, our measure of segment profit or loss, as net income excluding income tax expense, interest income, interest expense, other income or expense, gain or loss on debt extinguishment, depreciation, amortization, accretion, stock-based compensation expense, restructuring charges, impairment charges, transaction costs and gain or loss on asset sales. The accounting policies of the three segments are the same as those described in the summary of significant accounting policies, except that segment expenses exclude depreciation, amortization and accretion expense and stock-based compensation expense, consistent with the definition of adjusted EBITDA. | text | three | integerItemType | text: <entity> three </entity> <entity type> integerItemType </entity type> <context> We define adjusted EBITDA, our measure of segment profit or loss, as net income excluding income tax expense, interest income, interest expense, other income or expense, gain or loss on debt extinguishment, depreciation, amortization, accretion, stock-based compensation expense, restructuring charges, impairment charges, transaction costs and gain or loss on asset sales. The accounting policies of the three segments are the same as those described in the summary of significant accounting policies, except that segment expenses exclude depreciation, amortization and accretion expense and stock-based compensation expense, consistent with the definition of adjusted EBITDA. </context> | us-gaap:NumberOfReportableSegments |
Total revenues attributed to the U.S. were $ 3.3 billion. There was no other country from which we derived revenues that exceeded 10% of our total revenues and no single customer accounted for 10% or greater of our accounts receivable or revenues as at or for the year ended December 31, 2024. | text | 3.3 | monetaryItemType | text: <entity> 3.3 </entity> <entity type> monetaryItemType </entity type> <context> Total revenues attributed to the U.S. were $ 3.3 billion. There was no other country from which we derived revenues that exceeded 10% of our total revenues and no single customer accounted for 10% or greater of our accounts receivable or revenues as at or for the year ended December 31, 2024. </context> | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
Total revenues attributed to the U.S. and the United Kingdom were $ 3.1 billion and $ 822 million, respectively. There was no other country from which we derived revenues that exceeded 10% of our total revenues and no single customer accounted for 10% or greater of our accounts receivable or revenues as at or for the year ended December 31, 2023. | text | 3.1 | monetaryItemType | text: <entity> 3.1 </entity> <entity type> monetaryItemType </entity type> <context> Total revenues attributed to the U.S. and the United Kingdom were $ 3.1 billion and $ 822 million, respectively. There was no other country from which we derived revenues that exceeded 10% of our total revenues and no single customer accounted for 10% or greater of our accounts receivable or revenues as at or for the year ended December 31, 2023. </context> | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
Total revenues attributed to the U.S. and the United Kingdom were $ 3.1 billion and $ 822 million, respectively. There was no other country from which we derived revenues that exceeded 10% of our total revenues and no single customer accounted for 10% or greater of our accounts receivable or revenues as at or for the year ended December 31, 2023. | text | 822 | monetaryItemType | text: <entity> 822 </entity> <entity type> monetaryItemType </entity type> <context> Total revenues attributed to the U.S. and the United Kingdom were $ 3.1 billion and $ 822 million, respectively. There was no other country from which we derived revenues that exceeded 10% of our total revenues and no single customer accounted for 10% or greater of our accounts receivable or revenues as at or for the year ended December 31, 2023. </context> | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
Total revenues attributed to the U.S. were $ 2.9 billion. There was no other country from which we derived revenues that exceeded 10% of our total revenues and no single customer accounted for 10% or greater of our accounts receivable or revenues as at or for the year ended December 31, 2022. | text | 2.9 | monetaryItemType | text: <entity> 2.9 </entity> <entity type> monetaryItemType </entity type> <context> Total revenues attributed to the U.S. were $ 2.9 billion. There was no other country from which we derived revenues that exceeded 10% of our total revenues and no single customer accounted for 10% or greater of our accounts receivable or revenues as at or for the year ended December 31, 2022. </context> | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
Property, plant and equipment, net of $ 7.2 billion and $ 6.7 billion and operating lease right-of-use assets of $ 368 million and $ 398 million were located in the U.S. as of December 31, 2024 and 2023, respectively. | text | 7.2 | monetaryItemType | text: <entity> 7.2 </entity> <entity type> monetaryItemType </entity type> <context> Property, plant and equipment, net of $ 7.2 billion and $ 6.7 billion and operating lease right-of-use assets of $ 368 million and $ 398 million were located in the U.S. as of December 31, 2024 and 2023, respectively. </context> | us-gaap:PropertyPlantAndEquipmentNet |
Property, plant and equipment, net of $ 7.2 billion and $ 6.7 billion and operating lease right-of-use assets of $ 368 million and $ 398 million were located in the U.S. as of December 31, 2024 and 2023, respectively. | text | 6.7 | monetaryItemType | text: <entity> 6.7 </entity> <entity type> monetaryItemType </entity type> <context> Property, plant and equipment, net of $ 7.2 billion and $ 6.7 billion and operating lease right-of-use assets of $ 368 million and $ 398 million were located in the U.S. as of December 31, 2024 and 2023, respectively. </context> | us-gaap:PropertyPlantAndEquipmentNet |
Property, plant and equipment, net of $ 7.2 billion and $ 6.7 billion and operating lease right-of-use assets of $ 368 million and $ 398 million were located in the U.S. as of December 31, 2024 and 2023, respectively. | text | 368 | monetaryItemType | text: <entity> 368 </entity> <entity type> monetaryItemType </entity type> <context> Property, plant and equipment, net of $ 7.2 billion and $ 6.7 billion and operating lease right-of-use assets of $ 368 million and $ 398 million were located in the U.S. as of December 31, 2024 and 2023, respectively. </context> | us-gaap:OperatingLeaseRightOfUseAsset |
Property, plant and equipment, net of $ 7.2 billion and $ 6.7 billion and operating lease right-of-use assets of $ 368 million and $ 398 million were located in the U.S. as of December 31, 2024 and 2023, respectively. | text | 398 | monetaryItemType | text: <entity> 398 </entity> <entity type> monetaryItemType </entity type> <context> Property, plant and equipment, net of $ 7.2 billion and $ 6.7 billion and operating lease right-of-use assets of $ 368 million and $ 398 million were located in the U.S. as of December 31, 2024 and 2023, respectively. </context> | us-gaap:OperatingLeaseRightOfUseAsset |
On February 12, 2025, we declared a quarterly cash dividend of $ 4.69 per share, which is payable on March 19, 2025 to our common stockholders of record as of the close of business on February 26, 2025. | text | 4.69 | perShareItemType | text: <entity> 4.69 </entity> <entity type> perShareItemType </entity type> <context> On February 12, 2025, we declared a quarterly cash dividend of $ 4.69 per share, which is payable on March 19, 2025 to our common stockholders of record as of the close of business on February 26, 2025. </context> | us-gaap:CommonStockDividendsPerShareDeclared |
Long-term debt is presented at face value and excludes $ 24.2 million in letters of credit outstanding related to normal business transactions. Long-term debt includes the Live Oak CHP Project PACE Loan. For a description, refer to Part II, Item 8, Notes to Consolidated Financial Statements, “Note 13. Debt.” | text | 24.2 | monetaryItemType | text: <entity> 24.2 </entity> <entity type> monetaryItemType </entity type> <context> Long-term debt is presented at face value and excludes $ 24.2 million in letters of credit outstanding related to normal business transactions. Long-term debt includes the Live Oak CHP Project PACE Loan. For a description, refer to Part II, Item 8, Notes to Consolidated Financial Statements, “Note 13. Debt.” </context> | us-gaap:LettersOfCreditOutstandingAmount |
Pilgrim’s Pride Corporation (referred to herein as “Pilgrim’s,” “PPC,” “the Company,” “we,” “us,” “our,” or similar terms) is one of the largest food companies in the world, with operations in the United States (“U.S.”), the United Kingdom (“U.K.”), Mexico, France, Puerto Rico, the Netherlands and the Republic of Ireland. Pilgrim’s is primarily a chicken producer, with pork and lamb operations in the U.K. Pilgrim’s products are sold to foodservice, retail and frozen entrée customers. The Company’s primary distribution is through retailers, foodservice distributors and restaurants throughout the countries listed above. Additionally, the Company exports chicken and pork products (from its U.K. operations) to over 120 countries. Our fresh products consist of refrigerated whole or cut-up chicken, selected chicken parts that are either marinated or non-marinated, primary pork cuts, added value pork, pork ribs and lamb products. The Company’s prepared products include fully cooked, ready-to-cook and individually frozen chicken parts, strips, nuggets and patties, processed sausages, bacon, smoked meat, gammon joints, pre-packed meats, sandwich and deli counter meats and meat balls. The Company’s other products include plant-based protein offerings, ready-to-eat meals, multi-protein frozen foods, vegetarian foods and desserts. The Company also provides direct-to-consumer meals and hot food to-go solutions in the U.K. and the Republic of Ireland. We operate feed mills, hatcheries, processing plants and distribution centers in 14 U.S. states, the U.K., Mexico, France, Puerto Rico, the Netherlands and the Republic of Ireland. | text | 14 | integerItemType | text: <entity> 14 </entity> <entity type> integerItemType </entity type> <context> Pilgrim’s Pride Corporation (referred to herein as “Pilgrim’s,” “PPC,” “the Company,” “we,” “us,” “our,” or similar terms) is one of the largest food companies in the world, with operations in the United States (“U.S.”), the United Kingdom (“U.K.”), Mexico, France, Puerto Rico, the Netherlands and the Republic of Ireland. Pilgrim’s is primarily a chicken producer, with pork and lamb operations in the U.K. Pilgrim’s products are sold to foodservice, retail and frozen entrée customers. The Company’s primary distribution is through retailers, foodservice distributors and restaurants throughout the countries listed above. Additionally, the Company exports chicken and pork products (from its U.K. operations) to over 120 countries. Our fresh products consist of refrigerated whole or cut-up chicken, selected chicken parts that are either marinated or non-marinated, primary pork cuts, added value pork, pork ribs and lamb products. The Company’s prepared products include fully cooked, ready-to-cook and individually frozen chicken parts, strips, nuggets and patties, processed sausages, bacon, smoked meat, gammon joints, pre-packed meats, sandwich and deli counter meats and meat balls. The Company’s other products include plant-based protein offerings, ready-to-eat meals, multi-protein frozen foods, vegetarian foods and desserts. The Company also provides direct-to-consumer meals and hot food to-go solutions in the U.K. and the Republic of Ireland. We operate feed mills, hatcheries, processing plants and distribution centers in 14 U.S. states, the U.K., Mexico, France, Puerto Rico, the Netherlands and the Republic of Ireland. </context> | us-gaap:NumberOfStatesInWhichEntityOperates |
expense and totaled $ 70.1 million, $ 56.7 million and $ 58.0 million for 2024, 2023 and 2022, respectively. | text | 70.1 | monetaryItemType | text: <entity> 70.1 </entity> <entity type> monetaryItemType </entity type> <context> expense and totaled $ 70.1 million, $ 56.7 million and $ 58.0 million for 2024, 2023 and 2022, respectively. </context> | us-gaap:AdvertisingExpense |
expense and totaled $ 70.1 million, $ 56.7 million and $ 58.0 million for 2024, 2023 and 2022, respectively. | text | 56.7 | monetaryItemType | text: <entity> 56.7 </entity> <entity type> monetaryItemType </entity type> <context> expense and totaled $ 70.1 million, $ 56.7 million and $ 58.0 million for 2024, 2023 and 2022, respectively. </context> | us-gaap:AdvertisingExpense |
expense and totaled $ 70.1 million, $ 56.7 million and $ 58.0 million for 2024, 2023 and 2022, respectively. | text | 58.0 | monetaryItemType | text: <entity> 58.0 </entity> <entity type> monetaryItemType </entity type> <context> expense and totaled $ 70.1 million, $ 56.7 million and $ 58.0 million for 2024, 2023 and 2022, respectively. </context> | us-gaap:AdvertisingExpense |
Research and development costs are expensed as incurred. Research and development costs totaled $ 12.4 million, $ 5.7 million and $ 12.5 million for 2024, 2023 and 2022, respectively. | text | 12.4 | monetaryItemType | text: <entity> 12.4 </entity> <entity type> monetaryItemType </entity type> <context> Research and development costs are expensed as incurred. Research and development costs totaled $ 12.4 million, $ 5.7 million and $ 12.5 million for 2024, 2023 and 2022, respectively. </context> | us-gaap:ResearchAndDevelopmentExpense |
Research and development costs are expensed as incurred. Research and development costs totaled $ 12.4 million, $ 5.7 million and $ 12.5 million for 2024, 2023 and 2022, respectively. | text | 5.7 | monetaryItemType | text: <entity> 5.7 </entity> <entity type> monetaryItemType </entity type> <context> Research and development costs are expensed as incurred. Research and development costs totaled $ 12.4 million, $ 5.7 million and $ 12.5 million for 2024, 2023 and 2022, respectively. </context> | us-gaap:ResearchAndDevelopmentExpense |
Research and development costs are expensed as incurred. Research and development costs totaled $ 12.4 million, $ 5.7 million and $ 12.5 million for 2024, 2023 and 2022, respectively. | text | 12.5 | monetaryItemType | text: <entity> 12.5 </entity> <entity type> monetaryItemType </entity type> <context> Research and development costs are expensed as incurred. Research and development costs totaled $ 12.4 million, $ 5.7 million and $ 12.5 million for 2024, 2023 and 2022, respectively. </context> | us-gaap:ResearchAndDevelopmentExpense |
The Company is party to operating lease agreements for warehouses, office space, vehicle maintenance facilities and livestock growing farms in the U.S., distribution centers, hatcheries and office space in Mexico and farms, processing facilities and office space in Europe. Additionally, the Company leases equipment, over-the-road transportation vehicles and other assets in all three reportable segments. The Company is also party to a limited number of finance lease agreements in the U.S. | text | three | integerItemType | text: <entity> three </entity> <entity type> integerItemType </entity type> <context> The Company is party to operating lease agreements for warehouses, office space, vehicle maintenance facilities and livestock growing farms in the U.S., distribution centers, hatcheries and office space in Mexico and farms, processing facilities and office space in Europe. Additionally, the Company leases equipment, over-the-road transportation vehicles and other assets in all three reportable segments. The Company is also party to a limited number of finance lease agreements in the U.S. </context> | us-gaap:NumberOfOperatingSegments |
As of December 29, 2024, there were $ 2 million of pre-tax deferred net losses on foreign currency derivatives recorded in AOCI expected to be reclassified to the Consolidated Statements of Income during the next twelve months. This expectation is based on the anticipated settlements on the hedged investments in foreign currencies that will occur over the next twelve months, at which time the Company will recognize the deferred losses to earnings. | text | 2 | monetaryItemType | text: <entity> 2 </entity> <entity type> monetaryItemType </entity type> <context> As of December 29, 2024, there were $ 2 million of pre-tax deferred net losses on foreign currency derivatives recorded in AOCI expected to be reclassified to the Consolidated Statements of Income during the next twelve months. This expectation is based on the anticipated settlements on the hedged investments in foreign currencies that will occur over the next twelve months, at which time the Company will recognize the deferred losses to earnings. </context> | us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths |
In June 2023, the Company and JBS USA Food Company (“JBS USA”) jointly entered into a receivables purchase agreement with a bank for an uncommitted facility with a maximum capacity of $ 415.0 million and no recourse to the Company or JBS USA. Under the facility, the Company may sell eligible trade receivables in exchange for cash. Transfers under the agreement are recorded as a sale under ASC 860, | text | 415.0 | monetaryItemType | text: <entity> 415.0 </entity> <entity type> monetaryItemType </entity type> <context> In June 2023, the Company and JBS USA Food Company (“JBS USA”) jointly entered into a receivables purchase agreement with a bank for an uncommitted facility with a maximum capacity of $ 415.0 million and no recourse to the Company or JBS USA. Under the facility, the Company may sell eligible trade receivables in exchange for cash. Transfers under the agreement are recorded as a sale under ASC 860, </context> | us-gaap:LineOfCreditFacilityCapacityAvailableForTradePurchases |
Interest income and gross realized gains during 2024 and 2023 related to the Company’s available-for-sale securities totaled $ 70.8 million and $ 21.5 million, respectively, while gross realized losses were immaterial . Proceeds received from the sale or maturity of available-for-sale securities investments are historically disclosed in the Consolidated Statements of Cash Flows. Net unrealized holding gains and losses on the Company’s available-for-sale securities recognized during 2024 and 2023 that have been included in accumulated other comprehensive income (loss) and the net amount of gains and losses reclassified out of accumulated other comprehensive income (loss) to earnings during 2024 and 2023 are disclosed in “Note 14. Stockholders’ Equity.” | text | 70.8 | monetaryItemType | text: <entity> 70.8 </entity> <entity type> monetaryItemType </entity type> <context> Interest income and gross realized gains during 2024 and 2023 related to the Company’s available-for-sale securities totaled $ 70.8 million and $ 21.5 million, respectively, while gross realized losses were immaterial . Proceeds received from the sale or maturity of available-for-sale securities investments are historically disclosed in the Consolidated Statements of Cash Flows. Net unrealized holding gains and losses on the Company’s available-for-sale securities recognized during 2024 and 2023 that have been included in accumulated other comprehensive income (loss) and the net amount of gains and losses reclassified out of accumulated other comprehensive income (loss) to earnings during 2024 and 2023 are disclosed in “Note 14. Stockholders’ Equity.” </context> | us-gaap:DebtSecuritiesAvailableForSaleRealizedGain |
Interest income and gross realized gains during 2024 and 2023 related to the Company’s available-for-sale securities totaled $ 70.8 million and $ 21.5 million, respectively, while gross realized losses were immaterial . Proceeds received from the sale or maturity of available-for-sale securities investments are historically disclosed in the Consolidated Statements of Cash Flows. Net unrealized holding gains and losses on the Company’s available-for-sale securities recognized during 2024 and 2023 that have been included in accumulated other comprehensive income (loss) and the net amount of gains and losses reclassified out of accumulated other comprehensive income (loss) to earnings during 2024 and 2023 are disclosed in “Note 14. Stockholders’ Equity.” | text | 21.5 | monetaryItemType | text: <entity> 21.5 </entity> <entity type> monetaryItemType </entity type> <context> Interest income and gross realized gains during 2024 and 2023 related to the Company’s available-for-sale securities totaled $ 70.8 million and $ 21.5 million, respectively, while gross realized losses were immaterial . Proceeds received from the sale or maturity of available-for-sale securities investments are historically disclosed in the Consolidated Statements of Cash Flows. Net unrealized holding gains and losses on the Company’s available-for-sale securities recognized during 2024 and 2023 that have been included in accumulated other comprehensive income (loss) and the net amount of gains and losses reclassified out of accumulated other comprehensive income (loss) to earnings during 2024 and 2023 are disclosed in “Note 14. Stockholders’ Equity.” </context> | us-gaap:DebtSecuritiesAvailableForSaleRealizedGain |
The Company expects to recognize amortization expense associated with intangible assets of $ 32.4 million in 2025, $ 29.9 million in 2026, $ 24.9 million in 2027, 2028 and 2029. | text | 32.4 | monetaryItemType | text: <entity> 32.4 </entity> <entity type> monetaryItemType </entity type> <context> The Company expects to recognize amortization expense associated with intangible assets of $ 32.4 million in 2025, $ 29.9 million in 2026, $ 24.9 million in 2027, 2028 and 2029. </context> | us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths |
The Company expects to recognize amortization expense associated with intangible assets of $ 32.4 million in 2025, $ 29.9 million in 2026, $ 24.9 million in 2027, 2028 and 2029. | text | 29.9 | monetaryItemType | text: <entity> 29.9 </entity> <entity type> monetaryItemType </entity type> <context> The Company expects to recognize amortization expense associated with intangible assets of $ 32.4 million in 2025, $ 29.9 million in 2026, $ 24.9 million in 2027, 2028 and 2029. </context> | us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo |
The Company recognized depreciation expense of $ 401.2 million, $ 386.8 million and $ 369.4 million during 2024, 2023 and 2022, respectively. | text | 401.2 | monetaryItemType | text: <entity> 401.2 </entity> <entity type> monetaryItemType </entity type> <context> The Company recognized depreciation expense of $ 401.2 million, $ 386.8 million and $ 369.4 million during 2024, 2023 and 2022, respectively. </context> | us-gaap:Depreciation |
The Company recognized depreciation expense of $ 401.2 million, $ 386.8 million and $ 369.4 million during 2024, 2023 and 2022, respectively. | text | 386.8 | monetaryItemType | text: <entity> 386.8 </entity> <entity type> monetaryItemType </entity type> <context> The Company recognized depreciation expense of $ 401.2 million, $ 386.8 million and $ 369.4 million during 2024, 2023 and 2022, respectively. </context> | us-gaap:Depreciation |
The Company recognized depreciation expense of $ 401.2 million, $ 386.8 million and $ 369.4 million during 2024, 2023 and 2022, respectively. | text | 369.4 | monetaryItemType | text: <entity> 369.4 </entity> <entity type> monetaryItemType </entity type> <context> The Company recognized depreciation expense of $ 401.2 million, $ 386.8 million and $ 369.4 million during 2024, 2023 and 2022, respectively. </context> | us-gaap:Depreciation |
During 2024, the Company incurred $ 458.5 million on capital projects and transferred $ 633.0 million of completed projects from construction-in-progress to depreciable assets. Capital expenditures during 2024 were primarily incurred for growth projects, such as the Moorefield, WV expansion and the South Georgia protein conversion plant, and to improve operational efficiencies, information technology system enhancement projects, and to reduce costs. During 2023, the Company spent $ 557.8 million on capital projects and transferred $ 461.0 million of completed projects from construction-in-progress to depreciable assets. Capital expenditures in accounts payable and accrued expenses for the years ended December 29, 2024 and December 31, 2023 were $ 29.2 million and $ 85.9 million, respectively. | text | 458.5 | monetaryItemType | text: <entity> 458.5 </entity> <entity type> monetaryItemType </entity type> <context> During 2024, the Company incurred $ 458.5 million on capital projects and transferred $ 633.0 million of completed projects from construction-in-progress to depreciable assets. Capital expenditures during 2024 were primarily incurred for growth projects, such as the Moorefield, WV expansion and the South Georgia protein conversion plant, and to improve operational efficiencies, information technology system enhancement projects, and to reduce costs. During 2023, the Company spent $ 557.8 million on capital projects and transferred $ 461.0 million of completed projects from construction-in-progress to depreciable assets. Capital expenditures in accounts payable and accrued expenses for the years ended December 29, 2024 and December 31, 2023 were $ 29.2 million and $ 85.9 million, respectively. </context> | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
During 2024, the Company incurred $ 458.5 million on capital projects and transferred $ 633.0 million of completed projects from construction-in-progress to depreciable assets. Capital expenditures during 2024 were primarily incurred for growth projects, such as the Moorefield, WV expansion and the South Georgia protein conversion plant, and to improve operational efficiencies, information technology system enhancement projects, and to reduce costs. During 2023, the Company spent $ 557.8 million on capital projects and transferred $ 461.0 million of completed projects from construction-in-progress to depreciable assets. Capital expenditures in accounts payable and accrued expenses for the years ended December 29, 2024 and December 31, 2023 were $ 29.2 million and $ 85.9 million, respectively. | text | 633.0 | monetaryItemType | text: <entity> 633.0 </entity> <entity type> monetaryItemType </entity type> <context> During 2024, the Company incurred $ 458.5 million on capital projects and transferred $ 633.0 million of completed projects from construction-in-progress to depreciable assets. Capital expenditures during 2024 were primarily incurred for growth projects, such as the Moorefield, WV expansion and the South Georgia protein conversion plant, and to improve operational efficiencies, information technology system enhancement projects, and to reduce costs. During 2023, the Company spent $ 557.8 million on capital projects and transferred $ 461.0 million of completed projects from construction-in-progress to depreciable assets. Capital expenditures in accounts payable and accrued expenses for the years ended December 29, 2024 and December 31, 2023 were $ 29.2 million and $ 85.9 million, respectively. </context> | us-gaap:PropertyPlantAndEquipmentTransfersAndChanges |
During 2024, the Company incurred $ 458.5 million on capital projects and transferred $ 633.0 million of completed projects from construction-in-progress to depreciable assets. Capital expenditures during 2024 were primarily incurred for growth projects, such as the Moorefield, WV expansion and the South Georgia protein conversion plant, and to improve operational efficiencies, information technology system enhancement projects, and to reduce costs. During 2023, the Company spent $ 557.8 million on capital projects and transferred $ 461.0 million of completed projects from construction-in-progress to depreciable assets. Capital expenditures in accounts payable and accrued expenses for the years ended December 29, 2024 and December 31, 2023 were $ 29.2 million and $ 85.9 million, respectively. | text | 557.8 | monetaryItemType | text: <entity> 557.8 </entity> <entity type> monetaryItemType </entity type> <context> During 2024, the Company incurred $ 458.5 million on capital projects and transferred $ 633.0 million of completed projects from construction-in-progress to depreciable assets. Capital expenditures during 2024 were primarily incurred for growth projects, such as the Moorefield, WV expansion and the South Georgia protein conversion plant, and to improve operational efficiencies, information technology system enhancement projects, and to reduce costs. During 2023, the Company spent $ 557.8 million on capital projects and transferred $ 461.0 million of completed projects from construction-in-progress to depreciable assets. Capital expenditures in accounts payable and accrued expenses for the years ended December 29, 2024 and December 31, 2023 were $ 29.2 million and $ 85.9 million, respectively. </context> | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
During 2024, the Company incurred $ 458.5 million on capital projects and transferred $ 633.0 million of completed projects from construction-in-progress to depreciable assets. Capital expenditures during 2024 were primarily incurred for growth projects, such as the Moorefield, WV expansion and the South Georgia protein conversion plant, and to improve operational efficiencies, information technology system enhancement projects, and to reduce costs. During 2023, the Company spent $ 557.8 million on capital projects and transferred $ 461.0 million of completed projects from construction-in-progress to depreciable assets. Capital expenditures in accounts payable and accrued expenses for the years ended December 29, 2024 and December 31, 2023 were $ 29.2 million and $ 85.9 million, respectively. | text | 461.0 | monetaryItemType | text: <entity> 461.0 </entity> <entity type> monetaryItemType </entity type> <context> During 2024, the Company incurred $ 458.5 million on capital projects and transferred $ 633.0 million of completed projects from construction-in-progress to depreciable assets. Capital expenditures during 2024 were primarily incurred for growth projects, such as the Moorefield, WV expansion and the South Georgia protein conversion plant, and to improve operational efficiencies, information technology system enhancement projects, and to reduce costs. During 2023, the Company spent $ 557.8 million on capital projects and transferred $ 461.0 million of completed projects from construction-in-progress to depreciable assets. Capital expenditures in accounts payable and accrued expenses for the years ended December 29, 2024 and December 31, 2023 were $ 29.2 million and $ 85.9 million, respectively. </context> | us-gaap:PropertyPlantAndEquipmentTransfersAndChanges |
During 2024, the Company incurred $ 458.5 million on capital projects and transferred $ 633.0 million of completed projects from construction-in-progress to depreciable assets. Capital expenditures during 2024 were primarily incurred for growth projects, such as the Moorefield, WV expansion and the South Georgia protein conversion plant, and to improve operational efficiencies, information technology system enhancement projects, and to reduce costs. During 2023, the Company spent $ 557.8 million on capital projects and transferred $ 461.0 million of completed projects from construction-in-progress to depreciable assets. Capital expenditures in accounts payable and accrued expenses for the years ended December 29, 2024 and December 31, 2023 were $ 29.2 million and $ 85.9 million, respectively. | text | 29.2 | monetaryItemType | text: <entity> 29.2 </entity> <entity type> monetaryItemType </entity type> <context> During 2024, the Company incurred $ 458.5 million on capital projects and transferred $ 633.0 million of completed projects from construction-in-progress to depreciable assets. Capital expenditures during 2024 were primarily incurred for growth projects, such as the Moorefield, WV expansion and the South Georgia protein conversion plant, and to improve operational efficiencies, information technology system enhancement projects, and to reduce costs. During 2023, the Company spent $ 557.8 million on capital projects and transferred $ 461.0 million of completed projects from construction-in-progress to depreciable assets. Capital expenditures in accounts payable and accrued expenses for the years ended December 29, 2024 and December 31, 2023 were $ 29.2 million and $ 85.9 million, respectively. </context> | us-gaap:CapitalExpendituresIncurredButNotYetPaid |
During 2024, the Company incurred $ 458.5 million on capital projects and transferred $ 633.0 million of completed projects from construction-in-progress to depreciable assets. Capital expenditures during 2024 were primarily incurred for growth projects, such as the Moorefield, WV expansion and the South Georgia protein conversion plant, and to improve operational efficiencies, information technology system enhancement projects, and to reduce costs. During 2023, the Company spent $ 557.8 million on capital projects and transferred $ 461.0 million of completed projects from construction-in-progress to depreciable assets. Capital expenditures in accounts payable and accrued expenses for the years ended December 29, 2024 and December 31, 2023 were $ 29.2 million and $ 85.9 million, respectively. | text | 85.9 | monetaryItemType | text: <entity> 85.9 </entity> <entity type> monetaryItemType </entity type> <context> During 2024, the Company incurred $ 458.5 million on capital projects and transferred $ 633.0 million of completed projects from construction-in-progress to depreciable assets. Capital expenditures during 2024 were primarily incurred for growth projects, such as the Moorefield, WV expansion and the South Georgia protein conversion plant, and to improve operational efficiencies, information technology system enhancement projects, and to reduce costs. During 2023, the Company spent $ 557.8 million on capital projects and transferred $ 461.0 million of completed projects from construction-in-progress to depreciable assets. Capital expenditures in accounts payable and accrued expenses for the years ended December 29, 2024 and December 31, 2023 were $ 29.2 million and $ 85.9 million, respectively. </context> | us-gaap:CapitalExpendituresIncurredButNotYetPaid |
During 2024, the Company sold certain PP&E for $ 15.4 million and recognized a loss of $ 1.8 million. PP&E sold in 2024 consisted of a feed mill in the U.S., breeder farm equipment in Mexico, and other miscellaneous equipment. During 2023, | text | 15.4 | monetaryItemType | text: <entity> 15.4 </entity> <entity type> monetaryItemType </entity type> <context> During 2024, the Company sold certain PP&E for $ 15.4 million and recognized a loss of $ 1.8 million. PP&E sold in 2024 consisted of a feed mill in the U.S., breeder farm equipment in Mexico, and other miscellaneous equipment. During 2023, </context> | us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment |
During 2024, the Company sold certain PP&E for $ 15.4 million and recognized a loss of $ 1.8 million. PP&E sold in 2024 consisted of a feed mill in the U.S., breeder farm equipment in Mexico, and other miscellaneous equipment. During 2023, | text | 1.8 | monetaryItemType | text: <entity> 1.8 </entity> <entity type> monetaryItemType </entity type> <context> During 2024, the Company sold certain PP&E for $ 15.4 million and recognized a loss of $ 1.8 million. PP&E sold in 2024 consisted of a feed mill in the U.S., breeder farm equipment in Mexico, and other miscellaneous equipment. During 2023, </context> | us-gaap:GainLossOnSaleOfPropertyPlantEquipment |
the Company sold certain PP&E for $ 19.8 million and recognized a gain of $ 6.1 million. PP&E sold in 2023 consisted of a farm in Mexico and other miscellaneous equipment. | text | 19.8 | monetaryItemType | text: <entity> 19.8 </entity> <entity type> monetaryItemType </entity type> <context> the Company sold certain PP&E for $ 19.8 million and recognized a gain of $ 6.1 million. PP&E sold in 2023 consisted of a farm in Mexico and other miscellaneous equipment. </context> | us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment |
the Company sold certain PP&E for $ 19.8 million and recognized a gain of $ 6.1 million. PP&E sold in 2023 consisted of a farm in Mexico and other miscellaneous equipment. | text | 6.1 | monetaryItemType | text: <entity> 6.1 </entity> <entity type> monetaryItemType </entity type> <context> the Company sold certain PP&E for $ 19.8 million and recognized a gain of $ 6.1 million. PP&E sold in 2023 consisted of a farm in Mexico and other miscellaneous equipment. </context> | us-gaap:GainLossOnSaleOfPropertyPlantEquipment |
The Company has closed or idled various facilities in the U.S. and the U.K. The Board of Directors has not determined if it would be in the best interest of the Company to divest any of these idled assets. Management is therefore not certain that it can or will divest any of these assets within one year, is not actively marketing these assets and, accordingly, has not classified them as assets held for sale. The Company continues to depreciate these assets. As of December 29, 2024, the carrying amount of these idled assets was $ 45.1 million based on depreciable value of $ 185.8 million and accumulated depreciation of $ 140.7 million. During 2024, the Company recognized an impairment loss on PP&E of $ 28.6 million incurred as a result of planned restructuring activities in the Europe reportable segment. Additional information regarding restructuring activities is included in “Note 18. Restructuring-Related Activities.” | text | 28.6 | monetaryItemType | text: <entity> 28.6 </entity> <entity type> monetaryItemType </entity type> <context> The Company has closed or idled various facilities in the U.S. and the U.K. The Board of Directors has not determined if it would be in the best interest of the Company to divest any of these idled assets. Management is therefore not certain that it can or will divest any of these assets within one year, is not actively marketing these assets and, accordingly, has not classified them as assets held for sale. The Company continues to depreciate these assets. As of December 29, 2024, the carrying amount of these idled assets was $ 45.1 million based on depreciable value of $ 185.8 million and accumulated depreciation of $ 140.7 million. During 2024, the Company recognized an impairment loss on PP&E of $ 28.6 million incurred as a result of planned restructuring activities in the Europe reportable segment. Additional information regarding restructuring activities is included in “Note 18. Restructuring-Related Activities.” </context> | us-gaap:ImpairmentOfLongLivedAssetsHeldForUse |
The effective tax rate for 2024 was 23.0 % compared to 11.7 % for 2023 and 27.2 % for 2022. | text | 23.0 | percentItemType | text: <entity> 23.0 </entity> <entity type> percentItemType </entity type> <context> The effective tax rate for 2024 was 23.0 % compared to 11.7 % for 2023 and 27.2 % for 2022. </context> | us-gaap:EffectiveIncomeTaxRateContinuingOperations |
The effective tax rate for 2024 was 23.0 % compared to 11.7 % for 2023 and 27.2 % for 2022. | text | 11.7 | percentItemType | text: <entity> 11.7 </entity> <entity type> percentItemType </entity type> <context> The effective tax rate for 2024 was 23.0 % compared to 11.7 % for 2023 and 27.2 % for 2022. </context> | us-gaap:EffectiveIncomeTaxRateContinuingOperations |
The effective tax rate for 2024 was 23.0 % compared to 11.7 % for 2023 and 27.2 % for 2022. | text | 27.2 | percentItemType | text: <entity> 27.2 </entity> <entity type> percentItemType </entity type> <context> The effective tax rate for 2024 was 23.0 % compared to 11.7 % for 2023 and 27.2 % for 2022. </context> | us-gaap:EffectiveIncomeTaxRateContinuingOperations |
Included in the Mexico tax audit item in above table is an increase of 3.8 % in the effective tax rate related to the Mexican Tax Authority’s claim that Avícola Pilgrim’s Pride de Mexico, S.A. de C.V. (“Avícola”) should have considered dividends paid out of its subsidiaries as partially taxable in tax years 2009 and 2010. The amount was recorded during the year ended December 25, 2022. | text | 3.8 | percentItemType | text: <entity> 3.8 </entity> <entity type> percentItemType </entity type> <context> Included in the Mexico tax audit item in above table is an increase of 3.8 % in the effective tax rate related to the Mexican Tax Authority’s claim that Avícola Pilgrim’s Pride de Mexico, S.A. de C.V. (“Avícola”) should have considered dividends paid out of its subsidiaries as partially taxable in tax years 2009 and 2010. The amount was recorded during the year ended December 25, 2022. </context> | us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingenciesForeign |
As of December 29, 2024, the Company believes it has sufficient positive evidence to conclude that realization of its federal, state and foreign net deferred tax assets are more likely than not to be realized. As of December 29, 2024, the Company’s valuation allowance is $ 86.3 million, of which $ 10.6 million relates to our Europe operations, $ 0.3 million relates to our Mexico operations, $ 50.9 million relates to Onix Investments UK Limited, Sandstone Holdings Sàrl and Arkose Investments ULC, indirect subsidiaries of Pilgrim’s, $ 11.9 million relates to our Puerto Rico operations, $ 11.8 million relates to U.S. foreign tax credits and $ 0.8 million relates to state net operating losses. | text | 86.3 | monetaryItemType | text: <entity> 86.3 </entity> <entity type> monetaryItemType </entity type> <context> As of December 29, 2024, the Company believes it has sufficient positive evidence to conclude that realization of its federal, state and foreign net deferred tax assets are more likely than not to be realized. As of December 29, 2024, the Company’s valuation allowance is $ 86.3 million, of which $ 10.6 million relates to our Europe operations, $ 0.3 million relates to our Mexico operations, $ 50.9 million relates to Onix Investments UK Limited, Sandstone Holdings Sàrl and Arkose Investments ULC, indirect subsidiaries of Pilgrim’s, $ 11.9 million relates to our Puerto Rico operations, $ 11.8 million relates to U.S. foreign tax credits and $ 0.8 million relates to state net operating losses. </context> | us-gaap:DeferredTaxAssetsValuationAllowance |
As of December 29, 2024, the Company had federal and state net operating loss carry forwards of approximately $ 48.4 million that begin to expire in 2025. The Company also had Mexico net operating loss carry forwards as of December 29, 2024 of approximately $ 0.8 million that begin to expire in 2028. The Company also had U.K. net operating loss carry forwards as of December 29, 2024 of approximately $ 177.2 million that may be carried forward indefinitely. | text | 48.4 | monetaryItemType | text: <entity> 48.4 </entity> <entity type> monetaryItemType </entity type> <context> As of December 29, 2024, the Company had federal and state net operating loss carry forwards of approximately $ 48.4 million that begin to expire in 2025. The Company also had Mexico net operating loss carry forwards as of December 29, 2024 of approximately $ 0.8 million that begin to expire in 2028. The Company also had U.K. net operating loss carry forwards as of December 29, 2024 of approximately $ 177.2 million that may be carried forward indefinitely. </context> | us-gaap:OperatingLossCarryforwards |
As of December 29, 2024, the Company had federal and state net operating loss carry forwards of approximately $ 48.4 million that begin to expire in 2025. The Company also had Mexico net operating loss carry forwards as of December 29, 2024 of approximately $ 0.8 million that begin to expire in 2028. The Company also had U.K. net operating loss carry forwards as of December 29, 2024 of approximately $ 177.2 million that may be carried forward indefinitely. | text | 0.8 | monetaryItemType | text: <entity> 0.8 </entity> <entity type> monetaryItemType </entity type> <context> As of December 29, 2024, the Company had federal and state net operating loss carry forwards of approximately $ 48.4 million that begin to expire in 2025. The Company also had Mexico net operating loss carry forwards as of December 29, 2024 of approximately $ 0.8 million that begin to expire in 2028. The Company also had U.K. net operating loss carry forwards as of December 29, 2024 of approximately $ 177.2 million that may be carried forward indefinitely. </context> | us-gaap:OperatingLossCarryforwards |
As of December 29, 2024, the Company had federal and state net operating loss carry forwards of approximately $ 48.4 million that begin to expire in 2025. The Company also had Mexico net operating loss carry forwards as of December 29, 2024 of approximately $ 0.8 million that begin to expire in 2028. The Company also had U.K. net operating loss carry forwards as of December 29, 2024 of approximately $ 177.2 million that may be carried forward indefinitely. | text | 177.2 | monetaryItemType | text: <entity> 177.2 </entity> <entity type> monetaryItemType </entity type> <context> As of December 29, 2024, the Company had federal and state net operating loss carry forwards of approximately $ 48.4 million that begin to expire in 2025. The Company also had Mexico net operating loss carry forwards as of December 29, 2024 of approximately $ 0.8 million that begin to expire in 2028. The Company also had U.K. net operating loss carry forwards as of December 29, 2024 of approximately $ 177.2 million that may be carried forward indefinitely. </context> | us-gaap:OperatingLossCarryforwards |
As of December 29, 2024, the Company had approximately $ 5.4 million of state tax credit carry forwards that begin to expire in 2025. | text | 5.4 | monetaryItemType | text: <entity> 5.4 </entity> <entity type> monetaryItemType </entity type> <context> As of December 29, 2024, the Company had approximately $ 5.4 million of state tax credit carry forwards that begin to expire in 2025. </context> | us-gaap:TaxCreditCarryforwardAmount |
For the years ended December 29, 2024 and December 31, 2023, there is a tax effect of $( 9.4 ) million and $( 2.1 ) million, respectively, reflected in other comprehensive loss. | text | 9.4 | monetaryItemType | text: <entity> 9.4 </entity> <entity type> monetaryItemType </entity type> <context> For the years ended December 29, 2024 and December 31, 2023, there is a tax effect of $( 9.4 ) million and $( 2.1 ) million, respectively, reflected in other comprehensive loss. </context> | us-gaap:OtherComprehensiveIncomeLossTax |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.